164 related articles for article (PubMed ID: 37113779)
1. A single centre experience of prosthetic joint infection outcomes with outpatient parenteral antimicrobial therapy.
Kutubi A; O'Brien L; Murphy B; Fitzpatrick P; Hurson C; Rajendran D; Feeney E; Mallon P; Waqas S
Heliyon; 2023 Apr; 9(4):e15212. PubMed ID: 37113779
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of risk factors for readmission in patients receiving outpatient parenteral antimicrobial therapy.
Bradley AC; Wingler MJB; Artman KL; Ward LM; Lucar J
Ther Adv Infect Dis; 2023; 10():20499361231195966. PubMed ID: 37667754
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Hospital Readmission in Patients Receiving Outpatient Parenteral Antimicrobial Therapy.
Means L; Bleasdale S; Sikka M; Gross AE
Pharmacotherapy; 2016 Aug; 36(8):934-9. PubMed ID: 27393717
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and outcomes of patients receiving outpatient parenteral antibiotic therapy in a Belgian setting: a single-center pilot study.
Briquet C; Cornu O; Servais V; Blasson C; Vandeleene B; Yildiz H; Stainier A; Yombi JC
Acta Clin Belg; 2020 Aug; 75(4):275-283. PubMed ID: 31023169
[TBL] [Abstract][Full Text] [Related]
5. Outpatient parenteral antimicrobial therapy (OPAT) in Christchurch: 18 years on.
Chambers ST; Basevi A; Gallagher K; Carswell-Moyna A; Isenman H; Pithie A; Dalton S; Metcalf SC
N Z Med J; 2019 Aug; 132(1501):21-32. PubMed ID: 31465324
[TBL] [Abstract][Full Text] [Related]
6. Impact of the implementation of a nurse-managed outpatient parenteral antibiotic therapy (OPAT) system in Baltimore: a case study demonstrating cost savings and reduction in re-admission rates.
Mansour O; Heslin J; Townsend JL
J Antimicrob Chemother; 2018 Nov; 73(11):3181-3188. PubMed ID: 30085088
[TBL] [Abstract][Full Text] [Related]
7. Electronic health record-based readmission risk model performance for patients undergoing outpatient parenteral antibiotic therapy (OPAT).
Drew R; Brenneman E; Funaro J; Lee HJ; Yarrington M; Dicks K; Gallagher D
PLOS Digit Health; 2023 Aug; 2(8):e0000323. PubMed ID: 37531342
[TBL] [Abstract][Full Text] [Related]
8. Implementation of Outpatient Parenteral Antimicrobial Therapy (OPAT) in Patients with Complicated Periprosthetic Joint Infections.
Strassburg A; Weber AT; Kluba T
Z Orthop Unfall; 2024 May; ():. PubMed ID: 38802072
[TBL] [Abstract][Full Text] [Related]
9. Decreased hospital readmissions after programmatic strengthening of an outpatient parenteral antimicrobial therapy (OPAT) program.
Agnihotri G; Gross AE; Seok M; Yen CY; Khan F; Ebbitt LM; Gay C; Bleasdale SC; Sikka MK; Trotter AB
Antimicrob Steward Healthc Epidemiol; 2023; 3(1):e33. PubMed ID: 36865701
[TBL] [Abstract][Full Text] [Related]
10. Utility of a risk assessment model in predicting 30 day unplanned hospital readmission in adult patients receiving outpatient parenteral antimicrobial therapy.
Brenneman E; Funaro J; Dicks K; Yarrington M; Lee HJ; Erkanli A; Hung F; Drew R
JAC Antimicrob Resist; 2023 Feb; 5(1):dlad019. PubMed ID: 36824226
[TBL] [Abstract][Full Text] [Related]
11. Outpatient parenteral antibiotic therapy for the treatment of prosthetic knee and hip infections in Belgium, a cost minimization analysis.
Debaenst N; Seyler L; Putman K; Van Den Borre I; Vanlauwe J
Acta Clin Belg; 2022 Feb; 77(1):10-17. PubMed ID: 32484406
[TBL] [Abstract][Full Text] [Related]
12. Review of the first comprehensive outpatient parenteral antimicrobial therapy program in a tertiary care hospital in Japan.
Hase R; Yokoyama Y; Suzuki H; Uno S; Mikawa T; Suzuki D; Muranaka K; Hosokawa N
Int J Infect Dis; 2020 Jun; 95():210-215. PubMed ID: 32205285
[TBL] [Abstract][Full Text] [Related]
13. Outcomes and cost minimisation associated with outpatient parenteral antimicrobial therapy (OPAT) for foot infections in people with diabetes.
Malone M; West D; Xuan W; Lau NS; Maley M; Dickson HG
Diabetes Metab Res Rev; 2015 Sep; 31(6):638-45. PubMed ID: 25850572
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study.
Douiyeb S; de la Court JR; Tuinte B; Sombogaard F; Schade RP; Kuijvenhoven M; Minderhoud T; Sigaloff KCE
Int J Clin Pharm; 2022 Apr; 44(2):557-563. PubMed ID: 35157228
[TBL] [Abstract][Full Text] [Related]
15. Outpatient parenteral antimicrobial therapy at large Veterans Administration medical center.
Lai A; Tran T; Nguyen HM; Fleischmann J; Beenhouwer DO; Graber CJ
Am J Manag Care; 2013 Sep; 19(9):e317-24. PubMed ID: 24449959
[TBL] [Abstract][Full Text] [Related]
16. Evaluate the Effectiveness of Outpatient Parenteral Antimicrobial Therapy (OPAT) Program in Saudi Arabia: A Retrospective Study.
Al Shareef HJ; Al Harbi A; Alatawi Y; Aljabri A; Al-Ghanmi MA; Alzahrani MS; Algarni MA; Khobrani A; Haseeb A; AlSenani F; Elrggal ME
Antibiotics (Basel); 2022 Mar; 11(4):. PubMed ID: 35453192
[TBL] [Abstract][Full Text] [Related]
17. Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore.
Chan M; Ooi CK; Wong J; Zhong L; Lye D
BMC Infect Dis; 2017 Jul; 17(1):474. PubMed ID: 28683717
[TBL] [Abstract][Full Text] [Related]
18. Antifungal use via outpatient parenteral antimicrobial therapy.
Chew SM; Heath CH; Petursson C; Boan PA; Robinson JO; Italiano CM; Dyer JR; Manning L; Ingram PR
Mycoses; 2022 Oct; 65(10):946-952. PubMed ID: 35923125
[TBL] [Abstract][Full Text] [Related]
19. Patient Characteristics and Outcomes of Outpatient Parenteral Antimicrobial Therapy: A Retrospective Study.
Yan M; Elligsen M; Simor AE; Daneman N
Can J Infect Dis Med Microbiol; 2016; 2016():8435257. PubMed ID: 27366183
[TBL] [Abstract][Full Text] [Related]
20. Improving antimicrobial treatment in terms of antimicrobial stewardship and health costs by an OPAT service.
Burch AR; Ledergerber B; Ringer M; Padrutt M; Reiber C; Mayer F; Zinkernagel AS; Eberhard N; Kaelin MB; Hasse B
Infection; 2024 Feb; ():. PubMed ID: 38421503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
